Means and methods for anti-vegf therapy

The present application relates to the field of cancer, particularly to colorectal cancer (CRC). A panel of biomarkers is presented hereinthat can be used to cluster CRC samples into distinct genetic subtypes. It further relates to the use of the clustering method on patients treated with an anti-VEGF therapy and the identification of anti-VEGF responsive genetic subtypes.

Octrooi-publicatienummer: WO2017182656

Jaar aanvraag: 2017

Jaar toekenning: 2018

Jaar van publicatie: 2017

Status: Aangevraagd

Technologiedomeinen: Biotechnologie

Gevalideerd voor IOF-sleutel: Ja

Toegewezen aan: Associatie KULeuven